封面
市場調查報告書
商品編碼
1609701

2025-2033 年日本止血劑市場報告(按產品、配方、應用和地區)

Japan Hemostats Market Report by Product, Formulation, Application, and Region 2025-2033

出版日期: | 出版商: IMARC | 英文 119 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2024 年日本止血劑IMARC Group規模達 2.203 億美元。心血管疾病、癌症和糖尿病等慢性疾病的盛行率不斷上升,以及手術介入需求的不斷增加,正在推動市場的發展。

止血鉗是用於在醫療手術過程中控制出血的手術器械。它們由兩個鉸接的剪刀狀手柄組成,工作端帶有鋸齒狀鉗口。這些鉗口可以鎖定到位以夾住血管或組織,有效地將它們夾緊以防止進一步出血。止血鉗通常用於小型和大型手術以及急診室和牙科診所等各種醫療環境。止血鉗的關鍵功能是提供精確和暫時的血管閉塞,使醫療保健專業人員能夠安全有效地工作,而不會因過度失血而妨礙他們的手術。它們有各種尺寸和設計,具有直或彎曲的尖端,以滿足不同的手術需求。止血鉗也可用於在手術過程中抓住和操縱脆弱的組織。它們的多功能性使它們成為醫療領域的寶貴工具,有助於實現止血並確保成功的手術結果,同時最大限度地減少因失血過多而導致併發症的風險。

日本止血劑市場趨勢:

有幾個關鍵因素正在推動止血劑市場的成長。首先,日本外科手術數量的增加對止血劑產生了強烈的需求。隨著手術變得更加先進和微創,在這些手術過程中對有效止血劑控制出血的需求激增。此外,人口老化對市場擴張做出了重大貢獻。隨著老年人口的不斷增加,慢性病和外科手術(例如心血管和骨科手術)的發生率不斷上升,進一步推動了對止血產品的需求。此外,止血技術的進步在市場擴張中發揮了關鍵作用。具有增強功效和安全性的創新產品受到醫療保健專業人士的青睞,推動了市場成長。此外,醫療保健提供者和患者對止血產品及其益處的認知不斷提高,對市場動態產生了積極影響。此外,市場對研發活動的投資激增,促進了新型止血解決方案的推出。製藥公司和研究機構之間的合作正在突破創新的界限,為止血劑市場創造新的機會。這些相互關聯的促進因素正在推動區域止血劑市場的持續成長,並預計在未來幾年塑造其發展軌跡。

日本止血劑市場區隔:

產品見解:

  • 基於凝血酶
  • 基於組合
  • 氧化再生纖維素基
  • 明膠基
  • 基於膠原蛋白

配方見解:

  • 基質止血劑和凝膠止血劑
  • 止血片和止血墊
  • 海綿止血鉗
  • 粉末止血劑

應用見解:

  • 骨科手術
  • 一般外科
  • 神經外科
  • 心血管外科
  • 重建手術
  • 婦科手術
  • 其他

競爭格局:

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀表板和公司評估象限等競爭分析。此外,也提供了所有主要公司的詳細資料。

本報告回答的關鍵問題:

  • 到目前為止,日本止血劑市場表現如何,未來幾年又會如何表現?
  • COVID-19 對日本止血劑市場有何影響?
  • 日本止血劑市場依產品分類是怎樣的?
  • 日本止血劑市場依配方分類是怎樣的?
  • 日本止血劑市場的應用如何?
  • 日本止血劑市場價值鏈的各個階段是什麼?
  • 日本止血劑的關鍵促進因素和挑戰是什麼?
  • 日本止血劑市場的結構如何?
  • 日本止血劑市場的競爭程度如何?

本報告回答的關鍵問題:

  • 到目前為止,日本止血劑市場表現如何,未來幾年又會如何表現?
  • COVID-19 對日本止血劑市場有何影響?
  • 日本止血劑市場依產品分類是怎樣的?
  • 日本止血劑市場依配方分類是怎樣的?
  • 日本止血劑市場的應用如何?
  • 日本止血劑市場價值鏈的各個階段是什麼?
  • 日本止血劑的關鍵促進因素和挑戰是什麼?
  • 日本止血劑市場的結構如何?
  • 日本止血劑市場的競爭程度如何?

目錄

第1章:前言

第 2 章:範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章:執行摘要

第 4 章:日本止血劑市場 - 簡介

  • 概述
  • 市場動態
  • 產業動態
  • 競爭情報

第 5 章:日本止血劑市場格局

  • 歷史與當前市場趨勢(2019-2024)
  • 市場預測(2025-2033)

第 6 章:日本止血劑市場 - 細分:依產品分類

  • 基於凝血酶
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 基於組合
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 氧化再生纖維素基
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 明膠基
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 基於膠原蛋白
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)

第 7 章:日本止血劑市場 - 細分:按配方

  • 基質止血劑和凝膠止血劑
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 止血片和止血墊
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 海綿止血器
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 粉末止血劑
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)

第 8 章:日本止血劑市場 - 細分:按應用分類

  • 骨科手術
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 一般外科
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 神經外科
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 心血管外科
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 重建手術
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 婦科手術
    • 概述
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)
  • 其他
    • 歷史與當前市場趨勢(2019-2024)
    • 市場預測(2025-2033)

第 9 章:日本止血劑市場 - 競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳制勝策略
  • 競爭儀表板
  • 公司評估象限

第 10 章:關鍵參與者簡介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章:日本止血器市場 - 產業分析

  • 促進因素、限制因素和機會
    • 概述
    • 促進要素
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 12 章:附錄

簡介目錄
Product Code: SR112024A19019

Japan hemostats market size reached USD 220.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 362.6 Million by 2033, exhibiting a growth rate (CAGR) of 5.1% during 2025-2033. The escalating prevalence of chronic diseases such as cardiovascular diseases, cancer, and diabetes, along with the rising need for surgical interventions, is driving the market.

Hemostats are surgical instruments used to control bleeding during medical procedures. They consist of two hinged, scissor-like handles with serrated jaws at the working end. These jaws can be locked in place to grip blood vessels or tissues, effectively clamping them shut to prevent further bleeding. Hemostats are commonly used in surgeries, both minor and major, as well as in various medical settings like emergency rooms and dental offices. The key function of hemostats is to provide precise and temporary occlusion of blood vessels, allowing healthcare professionals to work safely and effectively without excessive bleeding hindering their procedures. They come in various sizes and designs, with straight or curved tips, to accommodate different surgical needs. Hemostats can also be used to grasp and manipulate delicate tissues during surgery. Their versatility makes them invaluable tools in the medical field, aiding in achieving hemostasis and ensuring successful surgical outcomes while minimizing the risk of complications due to excessive bleeding.

Japan Hemostats Market Trends:

Several key factors are driving growth in the hemostats market. Firstly, the increasing number of surgical procedures in Japan has created a robust demand for hemostatic agents. As surgeries become more advanced and minimally invasive, the need for effective hemostats to control bleeding during these procedures has surged. Furthermore, the aging population is contributing significantly to market expansion. With a growing elderly demographic, the incidence of chronic diseases and surgeries, such as cardiovascular and orthopedic procedures, has risen, further propelling the demand for hemostatic products. Additionally, advancements in hemostatic technologies have played a pivotal role in market expansion. Innovative products with enhanced efficacy and safety profiles have gained traction among healthcare professionals, driving market growth. Furthermore, the increasing awareness of hemostatic products and their benefits among both healthcare providers and patients has positively influenced market dynamics. Moreover, the market is witnessing a surge in investment in R&D activities, fostering the introduction of novel hemostatic solutions. Collaborations between pharmaceutical companies and research institutions are pushing the boundaries of innovation, creating new opportunities in the hemostats market. These interconnected drivers are fueling the regional hemostats market's continued growth and are expected to shape its trajectory in the coming years.

Japan Hemostats Market Segmentation:

Product Insights:

  • Thrombin Based
  • Combination Based
  • Oxidized Regenerated Cellulose Based
  • Gelatin Based
  • Collagen Based

Formulation Insights:

  • Matrix and Gel Hemostats
  • Sheet and Pad Hemostats
  • Sponge Hemostats
  • Powder Hemostats

Application Insights:

  • Orthopedic Surgery
  • General Surgery
  • Neurological Surgery
  • Cardiovascular Surgery
  • Reconstructive Surgery
  • Gynecological Surgery
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan hemostats market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan hemostats market?
  • What is the breakup of the Japan hemostats market on the basis of product?
  • What is the breakup of the Japan hemostats market on the basis of formulation?
  • What is the breakup of the Japan hemostats market on the basis of application?
  • What are the various stages in the value chain of the Japan hemostats market?
  • What are the key driving factors and challenges in the Japan hemostats?
  • What is the structure of the Japan hemostats market and who are the key players?
  • What is the degree of competition in the Japan hemostats market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Hemostats Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Hemostats Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Hemostats Market - Breakup by Product

  • 6.1 Thrombin Based
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Combination Based
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Oxidized Regenerated Cellulose Based
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Gelatin Based
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Collagen Based
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2019-2024)
    • 6.5.3 Market Forecast (2025-2033)

7 Japan Hemostats Market - Breakup by Formulation

  • 7.1 Matrix and Gel Hemostats
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Sheet and Pad Hemostats
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Sponge Hemostats
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)
  • 7.4 Powder Hemostats
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2019-2024)
    • 7.4.3 Market Forecast (2025-2033)

8 Japan Hemostats Market - Breakup by Application

  • 8.1 Orthopedic Surgery
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 General Surgery
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Neurological Surgery
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Cardiovascular Surgery
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Reconstructive Surgery
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2019-2024)
    • 8.5.3 Market Forecast (2025-2033)
  • 8.6 Gynecological Surgery
    • 8.6.1 Overview
    • 8.6.2 Historical and Current Market Trends (2019-2024)
    • 8.6.3 Market Forecast (2025-2033)
  • 8.7 Others
    • 8.7.1 Historical and Current Market Trends (2019-2024)
    • 8.7.2 Market Forecast (2025-2033)

9 Japan Hemostats Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Product Portfolio
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Product Portfolio
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Product Portfolio
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Product Portfolio
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Product Portfolio
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Hemostats Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix